Report cover image

Global and United States Eosinophilic Asthma Treatment Market Size, Status and Forecast 2021-2027

Publisher QYResearch Group
Published Jan 21, 2022
Length 82 Pages
SKU # QYR16931624

Description

Global and United States Eosinophilic Asthma Treatment Market Size, Status and Forecast 2021-2027

Summary

Market Analysis and Insights: Global Eosinophilic Asthma Treatment Market
This report focuses on global and United States Eosinophilic Asthma Treatment market.
In 2020, the global Eosinophilic Asthma Treatment market size was US$ 9901 million and it is expected to reach US$ 98355 million by the end of 2027, with a CAGR of 38.99% during 2021-2027. In United States the Eosinophilic Asthma Treatment market size is expected to grow from US$ 3590 million in 2020 to US$ 38112 million by 2027, at a CAGR of 40.24% during the forecast period.
Global Eosinophilic Asthma Treatment Scope and Market Size
Eosinophilic Asthma Treatment market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Eosinophilic Asthma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
By Company
Genentech(Roche Group)&Novartis
Regeneron Pharmaceuticals&Sanofi
Gsk
AstraZeneca
Teva Pharmaceutical

Segment by Type
Intravenous Infusion
Subcutaneous Injection

Segment by Application
Children
Teenagers
Adults

By Region
North America
United States
Canada

Asia-Pacific
Japan
India
Southeast Asia
Australia
Others

Europe
Germany
France
U.K.
Italy
Russia
Nordic

Latin America
Mexico
Brazil

Middle East & Africa
Middle East
Africa

Table of Contents

82 Pages
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Intravenous Infusion
1.2.3 Subcutaneous Injection
1.3 Market by Application
1.3.1 Global Eosinophilic Asthma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Children
1.3.3 Teenagers
1.3.4 Adults
1.4 Study Objectives
1.5 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global Eosinophilic Asthma Treatment Market Perspective (2016-2027)
2.2 Eosinophilic Asthma Treatment Growth Trends by Regions
2.2.1 Eosinophilic Asthma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Eosinophilic Asthma Treatment Historic Market Size by Regions (2016-2021)
2.2.3 Eosinophilic Asthma Treatment Forecasted Market Size by Regions (2022-2027)
2.2.4 United States Eosinophilic Asthma Treatment Market Share in Global Market 2016-2027
2.3 Eosinophilic Asthma Treatment Industry Dynamic
2.3.1 Eosinophilic Asthma Treatment Market Trends
2.3.2 Eosinophilic Asthma Treatment Market Drivers
2.3.3 Eosinophilic Asthma Treatment Market Challenges
2.3.4 Eosinophilic Asthma Treatment Market Restraints
3 THE NUMBER OF PATIENTS OF EOSINOPHILIC ASTHMA BY REGIONS
3.1 The Number of Patients of Eosinophilic Asthma by Regions (2019-2021)
3.2 The Prevalence Rate of Eosinophilic Asthma by Regions (2019-2021)
4 COMPETITION LANDSCAPE BY KEY PLAYERS
4.1 Global Top Eosinophilic Asthma Treatment Players by Revenue
4.1.1 Global Top Eosinophilic Asthma Treatment Players by Revenue (2016-2021)
4.1.2 Global Eosinophilic Asthma Treatment Revenue Market Share by Players (2016-2021)
4.2 Global Eosinophilic Asthma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Players Covered: Ranking by Eosinophilic Asthma Treatment Revenue
4.4 Global Eosinophilic Asthma Treatment Market Concentration Ratio
4.4.1 Global Eosinophilic Asthma Treatment Market Concentration Ratio (CR3 and HHI)
4.4.2 Global Top 3 Companies by Eosinophilic Asthma Treatment Revenue in 2020
4.5 Eosinophilic Asthma Treatment Key Players Head office
4.6 Key Players Eosinophilic Asthma Treatment Product Solution and Service
4.7 Date of Enter into Eosinophilic Asthma Treatment Market
4.8 Mergers & Acquisitions, Expansion Plans
5 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY TYPE
5.1 Global Eosinophilic Asthma Treatment Historic Market Size by Type (2016-2021)
5.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2022-2027)
6 EOSINOPHILIC ASTHMA TREATMENT BREAKDOWN DATA BY APPLICATION
6.1 Global Eosinophilic Asthma Treatment Historic Market Size by Application (2016-2021)
6.2 Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2022-2027)
7 NORTH AMERICA
7.1 North America Eosinophilic Asthma Treatment Market Size (2016-2027)
7.2 North America Eosinophilic Asthma Treatment Market Size by Type (2016-2021)
7.3 North America Eosinophilic Asthma Treatment Market Size by Application (2016-2021)
7.4 North America Eosinophilic Asthma Treatment Market Size by Country (2016-2021)
7.4.1 United States
7.4.2 Canada
8 EUROPE
8.1 Europe Eosinophilic Asthma Treatment Market Size (2016-2027)
8.2 Europe Eosinophilic Asthma Treatment Market Size by Type (2016-2021)
8.3 Europe Eosinophilic Asthma Treatment Market Size by Application (2016-2021)
8.4 Europe Eosinophilic Asthma Treatment Market Size by Country (2016-2021)
8.4.1 Germany
8.4.2 France
8.4.3 U.K.
8.4.4 Italy
8.4.5 Russia
8.4.6 Spain
9 ASIA-PACIFIC
9.1 Asia-Pacific Eosinophilic Asthma Treatment Market Size (2016-2027)
9.2 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Type (2016-2021)
9.3 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Application (2016-2021)
9.4 Asia-Pacific Eosinophilic Asthma Treatment Market Size by Country (2016-2021)
9.4.1 Japan
9.4.2 India
9.4.3 Southeast Asia
9.4.4 Australia
10 LATIN AMERICA
10.1 Latin America Eosinophilic Asthma Treatment Market Size (2016-2027)
10.2 Latin America Eosinophilic Asthma Treatment Market Size by Type (2016-2021)
10.3 Latin America Eosinophilic Asthma Treatment Market Size by Application (2016-2021)
10.4 Latin America Eosinophilic Asthma Treatment Market Size by Country (2016-2021)
10.4.1 Mexico
10.4.2 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Eosinophilic Asthma Treatment Market Size (2016-2027)
11.2 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2016-2021)
11.3 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2016-2021)
11.4 Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2016-2021)
11.4.1 Middle East
11.4.2 Africa
12 KEY PLAYERS PROFILES
12.1 Genentech(Roche Group)&Novartis
12.1.1 Genentech(Roche Group) Company Details
12.1.2 Genentech(Roche Group) Business Overview
12.1.3 Novartis Company Details
12.1.4 Novartis Business Overview
Sandoz Department
12.1.5 Genentech(Roche Group)&Novartis Eosinophilic Asthma Treatment Introduction
12.1.6 Genentech(Roche Group)&Novartis Revenue in Eosinophilic Asthma Treatment Business (2016-2021)
12.2 Regeneron Pharmaceuticals&Sanofi
12.2.1 Regeneron Pharmaceuticals Company Details
12.2.2 Regeneron Pharmaceuticals Business Overview
12.2.3 Sanofi Company Details
12.2.4 Sanofi Business Overview
12.2.5 Regeneron Pharmaceuticals&Sanofi Eosinophilic Asthma Treatment Introduction
12.2.6 Regeneron Pharmaceuticals&Sanofi Revenue in Eosinophilic Asthma Treatment Business (2016-2021)
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 GlaxoSmithKline Business Overview
12.3.3 GlaxoSmithKline Eosinophilic Asthma Treatment Introduction
12.3.4 GlaxoSmithKline Revenue in Eosinophilic Asthma Treatment Business (2016-2021)
12.4 AstraZeneca
12.4.1 AstraZeneca Company Details
12.4.2 AstraZeneca Business Overview
12.4.3 AstraZeneca Eosinophilic Asthma Treatment Introduction
12.4.4 AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2016-2021)
12.5 Teva Pharmaceutical Industries Ltd.
12.5.1 Teva Pharmaceutical Industries Ltd. Company Details
12.5.2 Teva Pharmaceutical Industries Ltd. Business Overview
12.5.3 Teva Pharmaceutical Industries Ltd. Eosinophilic Asthma Treatment Introduction
12.5.4 Teva Pharmaceutical Industries Ltd. Revenue in Eosinophilic Asthma Treatment Business (2016-2021)
13 ANALYST'S VIEWPOINTS/CONCLUSIONS
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Disclaimer
14.3 Author Details
List of Tables
Table 1. Global Eosinophilic Asthma Treatment Market Size Growth Rate by Type (US$ Million): 2016 VS 2021 VS 2027
Table 2. Key Players of Intravenous Infusion
Table 3. Key Players of Subcutaneous Injection
Table 4. Global Eosinophilic Asthma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Eosinophilic Asthma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Eosinophilic Asthma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Eosinophilic Asthma Treatment Market Share by Regions (2016-2021)
Table 8. Global Eosinophilic Asthma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Eosinophilic Asthma Treatment Market Share by Regions (2022-2027)
Table 10. Eosinophilic Asthma Treatment Market Trends
Table 11. Eosinophilic Asthma Treatment Market Drivers
Table 12. Eosinophilic Asthma Treatment Market Challenges
Table 13. Eosinophilic Asthma Treatment Market Restraints
Table 14. The Number of Patients of Eosinophilic Asthma by Regions (2019-2021) & (Thousands)
Table 15. The Prevalence Rate of Eosinophilic Asthma by Regions (2019-2021)
Table 16. Global Eosinophilic Asthma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Eosinophilic Asthma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Eosinophilic Asthma Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Eosinophilic Asthma Treatment as of 2020)
Table 19. Ranking of Global Top Eosinophilic Asthma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 3 Largest Players Market Share by Eosinophilic Asthma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters
Table 22. Key Players Eosinophilic Asthma Treatment Product Solution and Service
Table 23. Date of Enter into Eosinophilic Asthma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Eosinophilic Asthma Treatment Market Size by Type (2016-2021) & (US$ Million)
Table 26. Global Eosinophilic Asthma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Eosinophilic Asthma Treatment Forecasted Market Size by Type (2022-2027) & (US$ Million)
Table 28. Global Eosinophilic Asthma Treatment Revenue Market Share by Type (2022-2027)
Table 29. Global Eosinophilic Asthma Treatment Market Size by Application (2016-2021) & (US$ Million)
Table 30. Global Eosinophilic Asthma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Eosinophilic Asthma Treatment Forecasted Market Size by Application (2022-2027) & (US$ Million)
Table 32. Global Eosinophilic Asthma Treatment Revenue Market Share by Application (2022-2027)
Table 33. North America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) & (US$ Million)
Table 34. North America Eosinophilic Asthma Treatment Market Share by Type (2016-2021)
Table 35. North America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) & (US$ Million)
Table 36. North America Eosinophilic Asthma Treatment Market Share by Application (2016-2021)
Table 37. North America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Eosinophilic Asthma Treatment Market Share by Country (2016-2021)
Table 39. Europe Eosinophilic Asthma Treatment Market Size by Type (2016-2021) & (US$ Million)
Table 40. Europe Eosinophilic Asthma Treatment Market Share by Type (2016-2021)
Table 41. Europe Eosinophilic Asthma Treatment Market Size by Application (2016-2021) & (US$ Million)
Table 42. Europe Eosinophilic Asthma Treatment Market Share by Application (2016-2021)
Table 43. Europe Eosinophilic Asthma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Eosinophilic Asthma Treatment Market Share by Country (2016-2021)
Table 45. Asia-Pacific Eosinophilic Asthma Treatment Market Size by Type (2016-2021) & (US$ Million)
Table 46. Asia-Pacific Eosinophilic Asthma Treatment Market Share by Type (2016-2021)
Table 47. Asia-Pacific Eosinophilic Asthma Treatment Market Size by Application (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Eosinophilic Asthma Treatment Market Share by Application (2016-2021)
Table 49. Asia-Pacific Eosinophilic Asthma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Eosinophilic Asthma Treatment Market Share by Country (2016-2021)
Table 51. Latin America Eosinophilic Asthma Treatment Market Size by Type (2016-2021) & (US$ Million)
Table 52. Latin America Eosinophilic Asthma Treatment Market Share by Type (2016-2021
Table 53. Latin America Eosinophilic Asthma Treatment Market Size by Application (2016-2021) & (US$ Million)
Table 54. Latin America Eosinophilic Asthma Treatment Market Share by Application (2016-2021)
Table 55. Latin America Eosinophilic Asthma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Eosinophilic Asthma Treatment Market Share by Country (2016-2021)
Table 57. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Type (2016-2021) & (US$ Million)
Table 58. Middle East & Africa Eosinophilic Asthma Treatment Market Share by Type (2016-2021)
Table 59. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Application (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Eosinophilic Asthma Treatment Market Share by Application (2016-2021)
Table 61. Middle East & Africa Eosinophilic Asthma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Eosinophilic Asthma Treatment Market Share by Country (2016-2021)
Table 63. Genentech(Roche Group) Company Details
Table 64. Genentech(Roche Group) Business Overview
Table 65. Novartis Company Details
Table 66. Novartis Business Overview
Table 67. Genentech(Roche Group)&Novartis Eosinophilic Asthma Treatment Product
Table 68. Genentech(Roche Group)&Novartis Revenue in Eosinophilic Asthma Treatment Business (2016-2021) & (US$ Million)
Table 69. Regeneron Pharmaceuticals Company Details
Table 70. Regeneron Pharmaceuticals Business Overview
Table 71. Sanofi Company Details
Table 72. Regeneron Pharmaceuticals&Sanofi Business Overview
Table 73. Regeneron Pharmaceuticals&Sanofi Eosinophilic Asthma Treatment Product
Table 74. Regeneron Pharmaceuticals&Sanofi Revenue in Eosinophilic Asthma Treatment Business (2016-2021) & (US$ Million)
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Eosinophilic Asthma Treatment Product
Table 78. GlaxoSmithKline Revenue in Eosinophilic Asthma Treatment Business (2016-2021) & (US$ Million)
Table 79. AstraZeneca Company Details
Table 80. AstraZeneca Business Overview
Table 81. AstraZeneca Eosinophilic Asthma Treatment Product
Table 82. AstraZeneca Revenue in Eosinophilic Asthma Treatment Business (2016-2021) & (US$ Million)
Table 83. Teva Pharmaceutical Industries Ltd. Company Details
Table 84. Teva Pharmaceutical Industries Ltd. Business Overview
Table 85. Teva Pharmaceutical Industries Ltd. Eosinophilic Asthma Treatment Product
Table 86. Teva Pharmaceutical Industries Ltd. Revenue in Eosinophilic Asthma Treatment Business (2016-2021) & (US$ Million)
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Eosinophilic Asthma Treatment Market Share by Type: 2021 VS 2027
Figure 2. Intravenous Infusion Features
Figure 3. Subcutaneous Injection Features
Figure 4. Global Eosinophilic Asthma Treatment Market Share by Application: 2021 VS 2027
Figure 5. Children Case Studies
Figure 6. Teenagers Case Studies
Figure 7. Adults Case Studies
Figure 8. Eosinophilic Asthma Treatment Report Years Considered
Figure 9. Global Eosinophilic Asthma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us